Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Avadel Pharmaceuticals plc’s current trading price is -28.50% away from its 52-week high, while its distance from the 52-week low is 43.68%. The stock’s price range over this period has fluctuated between $9.50 and $19.09. The company, operating within the financial sector, had a trading volume of approximately 1.25 million for the day, which was noticeably lower than the average daily share volume of 1.28 million over the last 3 months.
Avadel Pharmaceuticals plc experienced a rather steady stock market performance. The highest value in the past year was recorded at $19.09 on 05/03/24 and the lowest value was $9.50 on 10/27/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Avadel Pharmaceuticals plc (AVDL) has experienced a quarterly decline of -10.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.31B and boasts a workforce of 154 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 15.94, with a change in price of -3.73. Similarly, Avadel Pharmaceuticals plc recorded 1,176,389 in trading volume during the last 100 days, posting a change of -21.46%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for AVDL stands at 0.54. Similarly, the long-term debt-to-equity ratio is also 0.52.
AVDL Stock Stochastic Average
Today, Avadel Pharmaceuticals plc’s raw stochastic average for the past 50 days stands at 4.95%, indicating a decline from the raw stochastic average of the last 20 days, which was 6.07%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 9.31% and 11.32% respectively.
AVDL Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -3.33%. However, over the past six months, we’ve seen a stronger performance of -14.53%. The price of AVDL leaped by -14.69% over the last 30 days. And in the last five days, it has fallen by -7.27%.
